PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AKT3 293 Target Disease Amyotrophic Lateral Sclerosis 14,006 3 0.00 -0.99 0.01 0.60
AKT3 293 Target Disease Autism 20,962 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Target EGF 27,487 8 0.00 -0.99 0.03 0.61
AKT3 293 Target Disease Leukemia 162,805 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Target ETS1 539 1 0.00 -1.00 0.00 0.67
AKT3 293 Target Disease Lung Cancer 91,416 9 0.00 -0.98 0.03 0.58
AKT3 293 Target Target BRAF 4,766 8 0.01 -0.99 0.03 0.67
AKT3 293 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.69
AKT3 293 Target Disease Breast Cancer 173,695 28 0.00 -0.95 0.10 0.59
AKT3 293 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Target ERK1 18,374 4 0.00 -0.99 0.01 0.60
AKT3 293 Target Disease Shock 134,031 3 0.00 -0.99 0.01 0.54
AKT3 293 Target Disease Arthritis 128,324 1 0.00 -1.00 0.00 0.52
AKT3 293 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
AKT2 873 Target Disease Diabetic Retinopathy 14,494 2 0.00 -1.00 0.00 0.57
AKT2 873 Target Disease Warts 5,574 1 0.00 -1.00 0.00 0.57
AKT2 873 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Glioblastoma 17,933 10 0.00 -0.99 0.01 0.61
AKT2 873 Target Disease Infertility 35,448 1 0.00 -1.00 0.00 0.53
AKT2 873 Target Target CCL21 808 1 0.00 -1.00 0.00 0.63
AKT2 873 Target Disease Irritable Bowel Syndrome 8,230 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.60
AKT2 873 Target Disease Inflammation 252,734 18 0.00 -0.99 0.02 0.55
AKT2 873 Target Target CCL1 220 1 0.00 -1.00 0.00 0.66
AKT2 873 Target Target BDNF 11,163 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Target Metabotropic Glutamate Receptor 1 221 2 0.00 -0.99 0.01 0.68
AKT2 873 Target Disease Leukemia 162,805 11 0.00 -0.99 0.01 0.55
AKT2 873 Target Disease Breast Cancer 173,695 61 0.00 -0.96 0.07 0.59
AKT2 873 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Brain Tumors 16,749 2 0.00 -1.00 0.00 0.56
AKT2 873 Target Target AXL 633 1 0.00 -1.00 0.00 0.64
AKT2 873 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Hyperlipidemia 15,317 1 0.00 -1.00 0.00 0.55
AKT2 873 Target Target ERBB3 1,154 5 0.00 -0.99 0.01 0.68
AKT2 873 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.53
AKT2 873 Target Target BRAF 4,766 14 0.01 -0.99 0.02 0.67
AKT2 873 Target Disease Heart Disease 118,291 2 0.00 -1.00 0.00 0.51
AKT2 873 Target Disease Lung Cancer 91,416 30 0.00 -0.98 0.03 0.59
AKT2 873 Target Target CD34 24,598 3 0.00 -1.00 0.00 0.56
AKT2 873 Target Target Elastase 13,875 1 0.00 -1.00 0.00 0.55
AKT2 873 Target Target BMP-2 3,889 2 0.00 -1.00 0.00 0.61
AKT2 873 Target Disease Ovarian Cyst 1,959 1 0.00 -1.00 0.00 0.61
AKT2 873 Target Disease Hyperlipoproteinemia 2,954 1 0.00 -1.00 0.00 0.59
AKT2 873 Target Target Glutamate Receptor 1 352 2 0.00 -1.00 0.01 0.67
AKT2 873 Target Drug Kaempferol 2,992 1 0.00 -1.00 0.00 0.59
AKT2 873 Target Drug Doxorubicin 28,033 3 0.00 -1.00 0.00 0.56
AKT2 873 Target Disease Liver Disease 49,817 6 0.00 -1.00 0.01 0.56
AKT2 873 Target Disease Pain 409,851 5 0.00 -1.00 0.01 0.51